Please assess the completion status of the following clinical trial:

Trial Title: CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of SLE, as defined by the American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus~Exclusion Criteria:~* age under 18 years~* known coronary artery disease~* impaired renal function with an estimated glomerular filtration rate less than 30 ml/min, estimated by the Modification of Diet in Renal Disease Study Group (MDRD) formula (45)~* devices as pacemakers, implantable cardioverter-defibrillators, insulin pumps and others~* metallic foreign bodies in the eyes, ferromagnetic implants labeled MR unsafe~* allergy against CMR contrast media or adenosine~* presence of chronic atrial fibrillation, 2nd or 3rd degree Atrioventricular (AV)-block, trifascicular block, asthma and severe chronic obstructive pulmonary disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).